Tenax Therapeutics, Inc. (TENX) financial statements (2020 and earlier)

Company profile

Business Address ONE COPLEY PARKWAY
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
4/30/2015
4/30/2014
4/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments51381317581
Cash and cash equivalents5122108581
Short-term investments00639  
Receivables  00000
Inventory, net of allowances, customer advances and progress billings     0
Inventory      0
Prepaid expense1000000
Other current assets    000
Other undisclosed current assets      0
Total current assets:61381418592
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Long-term investments and receivables  2931  
Long-term investments  2931  
Intangible assets, net (including goodwill)    33341
Goodwill    1111 
Intangible assets, net (excluding goodwill)    22231
Other noncurrent assets0001100
Other undisclosed noncurrent assets     00
Total noncurrent assets:0021065341
TOTAL ASSETS:613102383933
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3216412
Accounts payable2111101
Accrued liabilities1105311
Debt    000
Other undisclosed current liabilities  0011 
Total current liabilities:3216532
Noncurrent Liabilities
Long-term debt and lease obligation0     8
Long-term debt, excluding current maturities      8
Operating lease, liability0
Liabilities, other than long-term debt     00
Other liabilities     00
Other undisclosed noncurrent liabilities    88(5)
Total noncurrent liabilities:0   883
Total liabilities:321612115
Stockholders' equity
Stockholders' equity attributable to parent, including:4129177083(2)
Preferred stock      0
Common stock0000000
Additional paid in capital240240222222221219115
Accumulated other comprehensive income (loss)00(0)(0)0  
Accumulated deficit(236)(228)(213)(205)(151)(137)(117)
Warrants and rights outstanding    0  
Other undisclosed stockholders' equity attributable to parent00  (0)  
Total stockholders' equity:4129177083(2)
TOTAL LIABILITIES AND EQUITY:613102383933

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
4/30/2015
4/30/2014
4/30/2013
Revenues    001
Revenue, net  001
Cost of revenue
(Cost of Goods and Services Sold)
     (0)(0)
Other undisclosed gross profit     (0)(1)
Gross profit:    0(0)0
Operating expenses(9)(7)(9)(53)(15)(17)(6)
Other undisclosed operating income     01
Operating loss:(9)(7)(9)(53)(15)(17)(5)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
00011(1)0
Interest and debt expense    (0)(2)(4)
Loss from continuing operations before income taxes:(8)(7)(9)(52)(14)(20)(9)
Income tax benefit   8   
Net loss:(8)(7)(9)(44)(14)(20)(9)
Other undisclosed net loss attributable to parent (7)     
Net loss attributable to parent:(8)(14)(9)(44)(14)(20)(9)
Preferred stock dividends and other adjustments     (6)(1)
Other undisclosed net income available to common stockholders, basic   88285121
Net income (loss) available to common stockholders, basic:(8)(14)(9)44142510
Interest on convertible debt      (1)
Other undisclosed net loss available to common stockholders, diluted    (28)(51)(21)
Net income (loss) available to common stockholders, diluted:(8)(14)(9)44(14)(25)(12)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
4/30/2015
4/30/2014
4/30/2013
Net loss:(8)(7)(9)(44)(14)(20)(9)
Comprehensive loss:(8)(7)(9)(44)(14)(20)(9)
Other undisclosed comprehensive income, net of tax, attributable to parent1721188828  
Comprehensive income (loss), net of tax, attributable to parent:81494414(20)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: